Page last updated: 2024-08-17

uridine diphosphate and Atherogenesis

uridine diphosphate has been researched along with Atherogenesis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ayata, CK; Bode, C; Cicko, S; Dufner, B; Grimm, M; Hergeth, S; Hoppe, N; Idzko, M; Marchini, T; Michel, NA; Peikert, A; Reinöhl, J; Schulte, L; Stachon, P; von zur Muhlen, C; Wolf, D; Zirlik, A	1
Schiffmann, R	1
Bult, H; Fransen, P; Guns, PJ; Hendrickx, J; Van Assche, T	1

Reviews

1 review(s) available for uridine diphosphate and Atherogenesis

Article	Year
The consequences of genetic and pharmacologic reduction in sphingolipid synthesis. Journal of inherited metabolic disease, 2015, Volume: 38, Issue:1 Topics: Animals; Asthma; Atherosclerosis; Diabetes Mellitus; Disease Models, Animal; Glucose; Glucosyltransferases; Humans; Lipid Metabolism; Lysosomes; Mice; Polycystic Kidney Diseases; Serine C-Palmitoyltransferase; Sphingolipidoses; Sphingolipids; Uridine Diphosphate	2015

Article

Year

The consequences of genetic and pharmacologic reduction in sphingolipid synthesis.

Journal of inherited metabolic disease, 2015, Volume: 38, Issue:1

Topics: Animals; Asthma; Atherosclerosis; Diabetes Mellitus; Disease Models, Animal; Glucose; Glucosyltransferases; Humans; Lipid Metabolism; Lysosomes; Mice; Polycystic Kidney Diseases; Serine C-Palmitoyltransferase; Sphingolipidoses; Sphingolipids; Uridine Diphosphate

2015

Other Studies

2 other study(ies) available for uridine diphosphate and Atherogenesis

Article	Year
P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice. Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:10 Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Bone Marrow Transplantation; Cholesterol, Dietary; Disease Models, Animal; Inflammation; Inflammation Mediators; Leukocyte Rolling; Macrophages; Mice; Mice, Knockout; Plaque, Atherosclerotic; Receptors, LDL; Receptors, Purinergic P2; Signal Transduction; Time Factors; Transendothelial and Transepithelial Migration; Uridine Diphosphate	2014
P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice. British journal of pharmacology, 2010, Jan-01, Volume: 159, Issue:2 Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cell Line; Interleukin-6; Macrophages; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type II; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; RNA, Messenger; Suramin; Uridine Diphosphate	2010

Article

Year

P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.

Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:10

Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Bone Marrow Transplantation; Cholesterol, Dietary; Disease Models, Animal; Inflammation; Inflammation Mediators; Leukocyte Rolling; Macrophages; Mice; Mice, Knockout; Plaque, Atherosclerotic; Receptors, LDL; Receptors, Purinergic P2; Signal Transduction; Time Factors; Transendothelial and Transepithelial Migration; Uridine Diphosphate

2014

P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice.

British journal of pharmacology, 2010, Jan-01, Volume: 159, Issue:2

Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cell Line; Interleukin-6; Macrophages; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type II; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; RNA, Messenger; Suramin; Uridine Diphosphate

2010